Sandeep M. Patel

Sandeep M. Patel

Auto-generated profile, based on publicly available information

Sandeep M. Patel

Structural Heart & Intervention Center, Mercy Health-St. Rita's Medical Center, Lima, Ohio, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Circulation
Verified
Journal Article
Open access
PDF file
BSBenedikt Schrage
Benedikt Schrage
PBPeter Moritz Becher
Peter Moritz Becher
ABAlexander Bernhardt
Alexander Bernhardt
HBHiram Bezerra
Hiram Bezerra
SBStefan Blankenberg
Stefan Blankenberg
DWDirk Westermann
Dirk Westermann
Background: Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly used to treat cardiogenic shock. However, VA-ECMO might hamper myocardial recovery. The Impella unloads the left ventricle. This study aimed to evaluate whether left ventricular unloading in patients with cardiogenic shock treated with VA-ECMO was associated with lower mortality. Methods: Data from 686 consecutive patients with cardiogenic shock treated with VA-ECMO with or without left ventricular unloading using an Impella at 16 tertiary care centers in 4 countries were collected. The association between left ventricular unloading and 30-day mortality was assessed by Cox regression models in a 1:1 propensity score–matched cohort. Results: Left ventricular unloading was used in 337 of the 686 patients (49%). After matching, 255 patients with left ventricular unloading were compared with 255 patients without left ventricular unloading. In the matched cohort, left ventricular unloading was associated with lower 30-day mortality (hazard ratio, 0.79 [95% CI, 0.63–0.98]; P =0.03) without differences in various subgroups. Complications occurred more frequently in patients with left ventricular unloading: severe bleeding in 98 (38.4%) versus 45 (17.9%), access site–related ischemia in 55 (21.6%) versus 31 (12.3%), abdominal compartment in 23 (9.4%) versus 9 (3.7%), and renal replacement therapy in 148 (58.5%) versus 99 (39.1%). Conclusions: In this international, multicenter cohort study, left ventricular unloading was associated with lower mortality in patients with cardiogenic shock treated with VA-ECMO, despite higher complication rates. These findings support use of left ventricular unloading in patients with cardiogenic shock treated with VA-ECMO and call for further validation, ideally in a randomized, controlled trial.

8 December 2022 in ESC Heart Failure
Verified
Journal Article
Open access
HGHafez Golzarian
Hafez Golzarian
AMAlaha Mariam
Alaha Mariam
SSSidra R. Shah
Sidra R. Shah
BPBenjamin A. Pasley
Benjamin A. Pasley
SHSyed H. Haq
Syed H. Haq
SPSandeep M. Patel
Sandeep M. Patel
Amniotic fluid embolism (AFE) is a rare but potentially fatal complication of pregnancy. Prompt and aggressive resuscitative strategies are crucial in promoting survivability. We present a case of AFE resulting in cardiopulmonary collapse and subsequent cardiac arrest where we were able to safely deliver the baby and resuscitate the mother with veno-arterial extracorporeal membrane oxygenation and Impella CP—a novel combination known as ECPELLA. We discuss the implications of this approach as a more efficacious strategy in resuscitating AFE-induced cardiogenic shock and arrest.

24 October 2023 in European Heart Journal: Acute Cardiovascular Care
Verified
Journal Article
Closed access
PDF file
BBBenedikt N Beer
Benedikt N Beer
CKCaroline Kellner
Caroline Kellner
AGAlina Goßling
Alina Goßling
JSJonas Sundermeyer
Jonas Sundermeyer
LBLisa Besch
Lisa Besch
BSBenedikt Schrage
Benedikt Schrage
Aims: Veno-arterial extracorporeal membrane oxygenation therapy (VA-ECMO) restores circulation and tissue oxygenation in cardiogenic shock (CS) patients, but can also lead to complications. This study aimed to quantify VA-ECMO complications and analyse their association with overall survival as well as favourable neurological outcome (cerebral performance categories 1 + 2). Methods and results: All-comer patients with CS treated with VA-ECMO were retrospectively enrolled from 16 centres in four countries (2005–2019). Neurological, bleeding, and ischaemic adverse events (AEs) were considered. From these, typical VA-ECMO complications were identified and analysed separately as device-related complications. n = 501. Overall, 118 were women (24%), median age was 56.0 years, median lactate was 8.1 mmol/L. Acute myocardial infarction caused CS in 289 patients (58%). Thirty-days mortality was 40% (198/501 patients). At least one device-related complication occurred in 252/486 (52%) patients, neurological AEs in 108/469 (23%), bleeding in 192/480 (40%), ischaemic AEs in 123/478 (26%). The 22% of patients with the most AEs accounted for 50% of all AEs. All types of AEs were associated with a worse prognosis. Aside from neurological ones, all AEs and device-related complications were more likely to occur in women; although prediction of AEs outside of neurological AEs was generally poor. Conclusion: Therapy and device-related complications occur in half of all patients treated with VA-ECMO and are associated with a worse prognosis. They accumulate in some patients, especially in women. Aside from neurological events, identification of patients at risk is difficult, highlighting the need to establish additional quantitative markers of complication risk to guide VA-ECMO treatment in CS.

27 October 2023 in ESC Heart Failure
Verified
Journal Article
Open access
HGHafez Golzarian
Hafez Golzarian
ATArielle Thiel
Arielle Thiel
GHGerri Hempfling
Gerri Hempfling
MOMichael Otto
Michael Otto
TOTodd Otto
Todd Otto
SPSandeep M. Patel
Sandeep M. Patel
Conventional venoarterial extracorporeal membrane oxygenation (VA-ECMO) places a functional afterload burden on the left ventricle. In the setting of acute severe aortic insufficiency-induced cardiogenic shock, the utility of VA-ECMO in combination with a failing valve may result in catastrophic haemodynamic consequences. This challenge is compounded when the culprit is a failing surgical bioprosthetic valve. We present a case of severe rapid-onset bioprosthetic aortic insufficiency-induced cardiogenic shock successfully resuscitated with left atrial VA-ECMO promptly followed by emergent percutaneous valve-in-valve transaortic valve replacement. We discuss the logistics, implications, and associated haemodynamic manifestations in utilizing this strategy for such disease processes.

14 December 2020 in Cureus
Verified
Journal Article
Open access
PDF file
SASiddharth Agarwal
Siddharth Agarwal
CSChristopher Sosnofsky
Christopher Sosnofsky
JSJamie Saum
Jamie Saum
MAManu Aggarwal
Manu Aggarwal
SPSandeep Patel
Sandeep Patel
Intravenous catheters account for the majority of cases of upper extremity deep vein thrombosis (UEDVT), with a higher incidence in patients suffering from malignancy. Sequelae of UEDVT are similar to that of lower extremity DVT, comprising post-thrombotic syndrome and pulmonary embolism. While there are several treatment options for UEDVT including systemic anticoagulation, catheter-directed thrombolysis, and percutaneous mechanical thrombectomy, due to the absence of consistent guidelines regarding its management, treatment is often individualized based on patient characteristics, clinical factors, and technical considerations. We present a case of a 49-year-old female suffering from breast cancer with a central venous catheter (CVC) who came to the clinic with UEDVT and CVC malfunction and was successfully treated with mechanical thrombectomy using the ClotTriever System (Inari Medical, Irvine, CA). To our knowledge, this is the first report of the ClotTriever System being used to treat UEDVT and simultaneously salvage the CVC in a single session.

1 February 2021 in Journal of Cardiology Cases
Verified
Journal Article
Closed access
SASiddharth Agarwal
Siddharth Agarwal
JSJamie Saum
Jamie Saum
SCSreenivasa Chanamalou
Sreenivasa Chanamalou
WCWilliam Cole
William Cole
SPSandeep M. Patel
Sandeep M. Patel